Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2017

Open Access 01-12-2017 | Case report

Case report: rare skeletal manifestations in a child with primary hyperparathyroidism

Authors: Maulee Hiromi Arambewela, Kamani Danushka Liyanarachchi, Noel P. Somasundaram, Aruna S. Pallewatte, Gamini L. Punchihewa

Published in: BMC Endocrine Disorders | Issue 1/2017

Login to get access

Abstract

Background

Primary hyperparathyroidism (PHPT) is uncommon among children with an incidence of 1:300,000. This diagnosis is often missed in children in contrast to adults where it is detected at a pre symptomatic stage due to routine blood investigations. Etiology of PHPT can be due to adenoma, hyperplasia or rarely carcinoma.

Case presentation

A 12 year old Sri Lankan girl presented with progressive difficulty in walking since 1 year. On examination she had bilateral genu valgum. Skeletal survey revealed valgus deformity of knee joints, bilateral subluxation of upper femoral epiphysis(SUFE), epiphyseal displacement of bilateral humeri, rugger jersey spine and subperiosteal bone resorptions in lateral aspects of 2nd and 3rd middle phalanges. There were no radiological manifestations of rickets. Metabolic profile revealed hypercalcemia with hypophosphatemia. Intact parathyroid hormone levels were elevated at 790 pg/ml. Vitamin D levels were deficient. She had low bone mineral density with Z score of −3.4. Vitamin D supplementation resulted in worsening of hypercalcemia without reduction in PTH levels. Tc 99 Sestamibi uptake scan showed abnormal tracer retention in left inferior pole of thyroid. A large parathyroid gland was removed with histology favoring parathyroid adenoma. Post operatively she developed hypocalcemia. Bilateral osteotomy was done for SUFE and further surgeries for correction of limb deformities planned.

Conclusion

PHPT in children is usually diagnosed late when irreversible organ damage has occurred. Children can present with non specific symptoms involving gastrointestinal, musculoskeletal, renal and neurological systems. PHPT can cause disarray in bone and epiphysis in children during pubertal growth spurt. Genu valgum and SUFE are rare skeletal manifestations in PHPT and only 10 cases of genu valgum and 9 cases of SUFE have been reported up to now. So far no cases have been reported on epiphyseal displacement of humeri. Awareness regarding the occurrence of these rare skeletal manifestations especially during puberty is important for early diagnosis to prevent irreversible outcomes.
Literature
1.
go back to reference Alagarathnam S, Kurzawinski TR. Aetiology, diagnosis and surgical treatment of primary hyperaparathyroidism in children: new trends. Horm Res Paediatr. 2015;83:365–75.CrossRef Alagarathnam S, Kurzawinski TR. Aetiology, diagnosis and surgical treatment of primary hyperaparathyroidism in children: new trends. Horm Res Paediatr. 2015;83:365–75.CrossRef
2.
go back to reference Mallet E. Working group on calcium metabolism: primary hyperparathyroidism in neonates and childhood. The French experience (1984–2004). Horm Res. 2008;69:180–8.PubMed Mallet E. Working group on calcium metabolism: primary hyperparathyroidism in neonates and childhood. The French experience (1984–2004). Horm Res. 2008;69:180–8.PubMed
4.
go back to reference Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, Ishitani M, Rodeberg D. Primary hyperparathyroidism in pediatric patients. Pediatrics. 2005;115:974–80.CrossRefPubMed Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, Ishitani M, Rodeberg D. Primary hyperparathyroidism in pediatric patients. Pediatrics. 2005;115:974–80.CrossRefPubMed
5.
go back to reference Ramkumar S, Kandasamy D, Vijay MK. Etal. Genu valgum and primary hyperparathyroidism in children. Int. J. Case Rep Images. 2014;5(6):401–7.CrossRef Ramkumar S, Kandasamy D, Vijay MK. Etal. Genu valgum and primary hyperparathyroidism in children. Int. J. Case Rep Images. 2014;5(6):401–7.CrossRef
6.
go back to reference Rapaport D, Ziv Y, Rubin M, Huminer D, Dinstan M. Primary hyperparathyroidism in children. J Pediatr Surg. 1986;21(5):395–7.CrossRefPubMed Rapaport D, Ziv Y, Rubin M, Huminer D, Dinstan M. Primary hyperparathyroidism in children. J Pediatr Surg. 1986;21(5):395–7.CrossRefPubMed
7.
go back to reference Herring JA, Tachdjian MO. Tachdjian’s pediatric orthopaedics. Fourth ed. Philadelphia: Saunders; 2008. p. 716–20. Herring JA, Tachdjian MO. Tachdjian’s pediatric orthopaedics. Fourth ed. Philadelphia: Saunders; 2008. p. 716–20.
8.
go back to reference Loder RT, Wittenberg B, Desilva G. Slipped capital femoral epiphysis associated with endocrine disorders. J Paediatr Orthop. 1995;15(3):349–56.CrossRef Loder RT, Wittenberg B, Desilva G. Slipped capital femoral epiphysis associated with endocrine disorders. J Paediatr Orthop. 1995;15(3):349–56.CrossRef
9.
go back to reference El Scheich T, Marquard J, Westhoft B, et al. Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism. J Paediatr Endocinol Metab. 2012;25(5–6):407–12. El Scheich T, Marquard J, Westhoft B, et al. Approach to the management of slipped capital femoral epiphysis and primary hyperparathyroidism. J Paediatr Endocinol Metab. 2012;25(5–6):407–12.
10.
go back to reference Madeira IR, Machado M, Maya MC, et al. Primary hyperparathyroidism associated to slipped capital femoral epiphysis in a teenager. Arq Bras Endocrinol metabol. 2005;49(2):314–8.CrossRefPubMed Madeira IR, Machado M, Maya MC, et al. Primary hyperparathyroidism associated to slipped capital femoral epiphysis in a teenager. Arq Bras Endocrinol metabol. 2005;49(2):314–8.CrossRefPubMed
Metadata
Title
Case report: rare skeletal manifestations in a child with primary hyperparathyroidism
Authors
Maulee Hiromi Arambewela
Kamani Danushka Liyanarachchi
Noel P. Somasundaram
Aruna S. Pallewatte
Gamini L. Punchihewa
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2017
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-017-0197-z

Other articles of this Issue 1/2017

BMC Endocrine Disorders 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.